optum rx semaglutide to Provide Weight Loss Management Program Omada Health | News π£
Description
Leave your comments below!
After observing weight-loss in T2D patients, a once-daily injection of liraglutide (Novo Nordisks Saxenda) was approved for obesity in 2014
Data This study used a subset of Truveta data
Paper Summary Methodology Researchers conducted a target trial emulation study using electronic health records from the TriNetX Analytics platform, containing data from approximately 118 million patients across 68 healthcare organizations in the United States
Published purity for this product exceeds 99%, which is notably higher than the baseline 98% guarantee the company advertises
That's the part nobody's built infrastructure around and why Jurni GLP
